The judicial hammer has fallen. Kenneth Iwamasa, the personal assistant to the late actor Matthew Perry, was sentenced today to 12 months of supervised release and community service for his role in supplying the ketamine that led to Perry’s death. The case, though American, resonates deeply with a British legal tradition that has increasingly taken a hard line against those who enable fatal drug abuse.
Iwamasa, a 59-year-old who had worked for Perry for 25 years, admitted to injecting the actor with multiple doses of ketamine on the day he died. Prosecutors described him as a "deeply regretful" but essential cog in a machine of reckless supply. The judge’s sentence, lenient by some measures, still serves as a warning: enablers are now in the crosshairs.
For the UK, this is a familiar story. The Crown Prosecution Service has a long history of pursuing those who facilitate drug misuse, from dealers to the friends who supply fatal doses. In 2022, a man was jailed for 10 years after supplying heroin to a friend who overdosed. The message is clear: ignorance is no defence. If you hand over the substance, you bear the consequence.
But this case raises uncomfortable questions. Iwamasa was not a drug lord. He was an employee, a loyal assistant who became complicit in his boss’s addiction. The line between care and criminality blurred as Perry’s requests grew more desperate. The verdict suggests that even in the shadow of a celebrity’s demands, the law expects you to say no.
Yet the system itself could do more. Drug addiction is a public health crisis. In the UK, austerity-driven cuts to drug treatment services mean many addicts rely on informal networks, their friends and family becoming unwitting dealers. The judge in Perry’s case acknowledged Iwamasa’s remorse but stressed that “enabling a deadly habit” carries its own weight.
For working-class communities in the North, this hits home. We see it in the rising number of drug-related deaths, up 80% since 2012 in some regions. The law may be firm, but it often punishes the small fry while the larger supply chains remain intact. Perry’s death was a tragedy of fame, but the enablers here were not just one man. They were the doctors who prescribed, the dealers who sold, and a system that prioritises punishment over treatment.
The sentencing of Iwamasa is a moment for reflection. It is right that enablers face justice. But if the UK government wants to truly tackle drug deaths, it must invest in addiction services and harm reduction, not just harsher sentences. Without that, the real enablers remain unchecked.
